Please Note:

This questionnaire does not require you to share any proprietary information. Its purpose is to help Oakley Business Development prepare a tailored project plan for your review. Completing and submitting this form does not commit either party to further collaboration or create any financial obligation.

After Submission:

Once your questionnaire has been received, Oakley Business Development will review and analyse your responses. You will then receive an email outlining the next steps, should you wish to proceed.

This information is important to evaluate whether you product is a suitable for our specific market transfer program. To quickly evaluate readiness for transferring your manufacturing and packaging to a UK/EU site, please answer the following essential questions.

If multiple products are under consideration, please complete the form only for your lead sterile injectable candidate at this time.

Oakley Business Development Limited will contact you within 30 days to discuss the next stage of the project

With expertise across all dosage forms and stages of development, Oakley will review products outside this program’s scope on a case-by-case basis.

Data Protection: Oakley Business Development Limited complies with UK GDPR. Data is used solely for evaluation purposes and held securely. Contact BD@OakleyBD.com for any data-related enquiries.